These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 33322962)

  • 21. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
    Bailey SR; Crew EE; Riske EC; Ammerman S; Robinson TN; Killen JD
    Paediatr Drugs; 2012 Apr; 14(2):91-108. PubMed ID: 22248234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Searching for Personalized Medicine for Binge Drinking Smokers: Smoking Cessation Using Varenicline, Nicotine Patch, or Combination Nicotine Replacement Therapy.
    Kaye JT; Johnson AL; Baker TB; Piper ME; Cook JW
    J Stud Alcohol Drugs; 2020 Jul; 81(4):426-435. PubMed ID: 32800078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the pharmacotherapeutic interventions for smoking cessation.
    Barboza JL; Patel R; Patel P; Hudmon KS
    Expert Opin Pharmacother; 2016 Aug; 17(11):1483-96. PubMed ID: 27267498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidepressants for smoking cessation.
    Hajizadeh A; Howes S; Theodoulou A; Klemperer E; Hartmann-Boyce J; Livingstone-Banks J; Lindson N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD000031. PubMed ID: 37230961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current and emerging pharmacotherapies for treating tobacco dependence.
    Schnoll RA; Lerman C
    Expert Opin Emerg Drugs; 2006 Sep; 11(3):429-44. PubMed ID: 16939383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006103. PubMed ID: 17253581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physician barriers to incorporating pharmacogenetic treatment strategies for nicotine dependence into clinical practice.
    Schnoll RA; Shields AE
    Clin Pharmacol Ther; 2011 Mar; 89(3):345-7. PubMed ID: 21326262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-Reported Quit Aids and Assistance Used By Smokers At Their Most Recent Quit Attempt: Findings from the 2020 International Tobacco Control Four Country Smoking and Vaping Survey.
    Gravely S; Cummings KM; Hammond D; Borland R; McNeill A; East KA; Loewen R; Martin N; Yong HH; Li L; Liber A; Levy DT; Quah ACK; Ouimet J; Hitchman SC; Thompson ME; Boudreau C; Fong GT
    Nicotine Tob Res; 2021 Aug; 23(10):1699-1707. PubMed ID: 33837435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-nicotinic therapies for smoking cessation.
    Siu EC; Tyndale RF
    Annu Rev Pharmacol Toxicol; 2007; 47():541-64. PubMed ID: 17209799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
    Uhl GR; Liu QR; Drgon T; Johnson C; Walther D; Rose JE; David SP; Niaura R; Lerman C
    Arch Gen Psychiatry; 2008 Jun; 65(6):683-93. PubMed ID: 18519826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
    Eisenberg MJ; Filion KB; Yavin D; Bélisle P; Mottillo S; Joseph L; Gervais A; O'Loughlin J; Paradis G; Rinfret S; Pilote L
    CMAJ; 2008 Jul; 179(2):135-44. PubMed ID: 18625984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review.
    Kozak K; George TP
    Expert Opin Pharmacother; 2020 Apr; 21(5):581-590. PubMed ID: 32011186
    [No Abstract]   [Full Text] [Related]  

  • 38. Nicotine receptor partial agonists for smoking cessation.
    Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
    Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD007253. PubMed ID: 23450574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical therapy for smoking cessation].
    Zeller A
    Ther Umsch; 2010 Aug; 67(8):419-25. PubMed ID: 20687045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.